Navigation Links
Differing attitudes found between women and doctors concerning menstrual suppression
Date:10/3/2007

. Barnhart. Menstruation is not medically necessary. Now that we have products that have proven to be safe and effective at suppressing menstruation, we can offer increasing options for women.

Indeed it seems a clearer patient-physician dialogue is required to eliminate confusion regarding menstrual suppression and continuous use oral contraceptives. Of the 12% of patients who indicated that they have discussed the idea of eliminating or reducing periods with their doctor; nearly half of those said that they were the ones to raise the issue, not their physicians. But their physicians tell a different story. By contrast, four out of 5 physicians reported discussing continuous use oral contraceptive use with their patients, and 77% reported that they raised the topic.

This disconnect may be related to simple semantics, according to Dr. Barnhart.

Weve found that physicians and their patients discuss this topic differently, with doctors using the medical term menstrual suppression, while their patients simply talk about not having a period, he said. Breaking down this language barrier by speaking in simpler, more patient-friendly terms could have a significant positive impact on understanding.

Oral contraceptives were initially designed with a week of inactive tablets taken every month to mimic the natural experience of menstruation. Continuous use oral contraceptives simply eliminate these inactive tablets, thereby eliminating withdrawal bleeding. A study published in the December, 2006 issue of Contraception demonstrated the safety and effectiveness of continuous-use oral contraceptives that can eliminate menstrual cycles. Researchers concluded that a continuous-use, low-dose regimen of oral contraceptives was safe and as effective as traditional oral contraceptives, and that the decrease in menstrual cycle symptoms during continuous use therapy represented an increase in quality of life.


'/>"/>

Contact: Marc Kaplan
marc.kaplan@uphs.upenn.edu
215-662-2560
University of Pennsylvania School of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Differing reactions to anti clotting drugs may be due to genetic variation.
2. Differing Ideas on Management of Alzheimer’s diseas
3. Risk Attitudes And Consequences Of College Drinking
4. Attitudes About Aging Different from Reality
5. Sexual Attitudes Help Explain Narcissists’ Relationship Problem
6. Men and Women Change Attitudes to Sex When in an Intimate Relationship
7. High-risk Sexual Behavior Adolescents Attract Peers With Similar Attitudes
8. Distraction therapy found very effective in postoperative patients
9. Genetic differences found between Male and Female brains
10. Breastfeeding not found to have an impact on weight of the child.
11. Common Cold Found to Fight Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... May 19, 2013 The Pradaxa lawyers ... Conference was recently convened for hundreds of Pradaxa ... now underway in U.S. District Court, Southern District of ... website on May 14th, the Conference addressed the status ... reported during the Conference that Defendants submitted a list ...
(Date:5/19/2013)... The Fat Loss Code program developed by Shawn Stevenson covers ... get in shape, and gain a healthy life regardless of ... a natural fat loss system that provides people with effective ... loss diet program claimed that The Fat Loss Code is ... fat off long-term. After Shawn Stevenson launched this new body ...
(Date:5/19/2013)... 2013 Exciting new Skin Brushes are ... a great practice known through the ages but is ... dry body brushing, has so many benefits for our ... Beauty®. "We love that circulation and lymphatic systems get ... the skin, is supported through Skin Brushing." , Why ...
(Date:5/19/2013)... Atlanta, GA (PRWEB) May 19, 2013 The ... and 2pm at the Columbus Georgia Convention & Trade Center ... are invited to attend. AMTC auditions are free of charge. ... the starting point for hundreds of successful artists and grads ... new face for European Tombolini , Chris Young - on ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The Da ... to follow developments in the nation’s first trial involving ... underway in Washington State Superior Court, was filed by ... after he suffered complications in a robot-assisted prostate removal, ... Da Vinci robotic surgery lawsuit alleges those ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4
... researchers looked at the distribution of primary stroke ... national organizations (such as The Joint Commission in ... They found that 24 percent of acute general ... the eight states that have a state-based program ...
... in the brains of patients with Alzheimer disease collude, resulting ... cells, according to new findings published online in Neurobiology ... pathological forms of two proteins, amyloid beta and tau, which ... patients plaques and tangles may work in tandem ...
... Researchers from Boston Medical Center (BMC) and Boston ... use as a risk factor for not receiving all ... in BMJ Open, identify unhealthy substance use ... influenza vaccination. Cancer and influenza ...
... influences decision making on issues whose consequences will only ... the annual Addiction Science Awards at this year,s Intel ... largest science competition for high school students. The Intel ... ceremony Thursday night in Los Angeles. The awards were ...
... Elsevier, the world,s leading publisher of scientific ... India,s first contract research organization, has signed a ... Reaxys for all Syngene researchers. Reaxys will help ... the ever-expanding and highly competitive Indian pharmaceutical, chemical ...
... This release is also available in Chinese on ... the discomfort and pain some people experience while using in-ear ... canal from external sound -- have found not only what ... In two separate papers and a presentation at the 130th ...
Cached Medicine News:Health News:2 defective proteins conspire to impair the nerve cell's 'powerhouse' in Alzheimer's disease 2Health News:2 defective proteins conspire to impair the nerve cell's 'powerhouse' in Alzheimer's disease 3Health News:Study finds unhealthy substance use a risk factor for not receiving some preventive health services 2Health News:Altruistic decision making focus of NIDA's Addiction Science Award 2Health News:Altruistic decision making focus of NIDA's Addiction Science Award 3Health News:Sound safety 2Health News:Sound safety 3Health News:Sound safety 4Health News:Sound safety 5
(Date:5/16/2013)... and MECHELEN, Belgium , May 17, ... (NYSE: ABBV ) announced today an extension ... disease.  Galapagos will fund and complete a Phase 2 ... rapid progression into Phase 3.  Upon successful completion of ... Galapagos $50 million.  The terms of the collaboration extension ...
(Date:5/16/2013)... , May 16, 2013  HeartWare International, Inc. (NASDAQ: ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... Doug Godshall is scheduled to present ... EDT on Monday, May 20, 2013.  The conference is being ... A live webcast of the Company,s presentation at ...
(Date:5/16/2013)... , May 16, 2013 ... in the U.S. to access the widely-used OrthoView digital ... PC and Internet connection to get started. ... software for over 10 years, is dedicated to enabling ... with digital x-ray images, when printed film is unavailable. ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
... , - Marketing ... for Tetrabenazine in H1 2009 , ... Finland (MediFront) and Taiwan,(Giddi Pharma); Distribution Contracts Renewed in ... Cambridge Laboratories Limited ("Cambridge" or "the Company"), ...
... FRANCISCO, Dec. 7 Millennium: The Takeda ... from a randomized, multi-center,Company-sponsored Phase I/II study ... patients with previously untreated multiple,myeloma (MM). The ... that the,combination of four drugs was generally ...
Cached Medicine Technology:Cambridge Laboratories Announces Approval of Tetrabenazine in Spain 2Cambridge Laboratories Announces Approval of Tetrabenazine in Spain 3Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 2Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 3Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 4Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 5Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 6
... This is the only ... counts in patient synovial fluid ... hemocytometer. It is also an ... which may indicate a pathological ...
... is intended as a means ... assay methods used for the ... urine samples. This control is ... This control is supplied as ...
... validates urine dipstick readings by applying the ... plastic dropper tip designed for easy dispensing ... the addition of creatinine and microalbumin. Assay ... results for hCG for early pregnancy detection ...
... Pyrogallol Red Molybdate dye binding ... method for total protein quantitation with ... urine or cerebrospinal fluid (CSF) in ... includes four reagent standards (level 2, ...
Medicine Products: